• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国国立医学图书馆临床试验数据库:希望参与研究的孕妇面临的陷阱。

ClinicalTrials.Gov: Pitfalls for pregnant women looking to enroll in studies.

作者信息

Franceschini Robert, Wicks Sarah L

机构信息

BluePath Health, 80 E Sir Francis Drake Blvd, Suite 4H Larkspur, CA 94939 USA.

Goodwin Procter LLP, 1900 N Street NW, Washington, DC, 20036, USA.

出版信息

Contemp Clin Trials Commun. 2022 Jan 20;26:100890. doi: 10.1016/j.conctc.2022.100890. eCollection 2022 Apr.

DOI:10.1016/j.conctc.2022.100890
PMID:35128141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8810363/
Abstract

The common exclusion of pregnant women from clinical HIV research warrants inquiry into those few studies that do include pregnant women. This commentary highlights some of the pitfalls of the ClinicalTrials.gov platform for its intended users--study participants, particularly pregnant women--and investigators looking to use its data for study. Some of the pitfalls include missing information; lack of historical reporting enforcement; difficulty searching for studies focused on pregnant women versus the fetus; inability to consistently find studies targeted at specific stages of pregnancy; and lack of information relating to whether a study intervention is investigational or previously approved by the FDA.

摘要

临床HIV研究通常将孕妇排除在外,因此有必要对少数纳入孕妇的研究进行调查。本评论强调了ClinicalTrials.gov平台对于其目标用户(研究参与者,尤其是孕妇)以及希望使用其数据进行研究的研究者而言存在的一些缺陷。其中一些缺陷包括信息缺失;缺乏对历史报告的强制要求;难以搜索针对孕妇而非胎儿的研究;无法始终找到针对特定孕期阶段的研究;以及缺乏有关研究干预措施是试验性的还是已获美国食品药品监督管理局(FDA)批准的信息。

相似文献

1
ClinicalTrials.Gov: Pitfalls for pregnant women looking to enroll in studies.美国国立医学图书馆临床试验数据库:希望参与研究的孕妇面临的陷阱。
Contemp Clin Trials Commun. 2022 Jan 20;26:100890. doi: 10.1016/j.conctc.2022.100890. eCollection 2022 Apr.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Interventions with pregnant women, new mothers and other primary caregivers for preventing early childhood caries.干预孕妇、新妈妈和其他主要照顾者以预防幼儿龋齿。
Cochrane Database Syst Rev. 2024 May 16;5(5):CD012155. doi: 10.1002/14651858.CD012155.pub3.
4
Treating periodontal disease for preventing adverse birth outcomes in pregnant women.治疗牙周疾病以预防孕妇不良分娩结局。
Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD005297. doi: 10.1002/14651858.CD005297.pub3.
5
Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.在怀孕前或怀孕早期开始补钙,或对食物进行钙强化,以预防妊娠期高血压疾病。
Cochrane Database Syst Rev. 2017 Sep 26;9(9):CD011192. doi: 10.1002/14651858.CD011192.pub2.
6
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.干预影响一氧化氮通路与安慰剂或无治疗妊娠胎儿生长受限。
Cochrane Database Syst Rev. 2023 Jul 10;7(7):CD014498. doi: 10.1002/14651858.CD014498.
7
Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility.妊娠危及生命的血液系统恶性肿瘤的免疫化疗:文献系统评价和临床试验资格的横断面分析。
Lancet Haematol. 2023 Jun;10(6):e458-e467. doi: 10.1016/S2352-3026(23)00059-5.
8
Zinc supplementation for improving pregnancy and infant outcome.补锌用于改善妊娠结局和婴儿结局。
Cochrane Database Syst Rev. 2021 Mar 16;3(3):CD000230. doi: 10.1002/14651858.CD000230.pub6.
9
10

引用本文的文献

1
Collaborative care for pregnant women with eye conditions.患有眼部疾病孕妇的协作式护理。
Clin Med (Lond). 2025 Apr 5;25(3):100314. doi: 10.1016/j.clinme.2025.100314.
2
Sex as a Biological Variable in Tissue Engineering and Regenerative Medicine.性作为组织工程和再生医学中的生物学变量。
Annu Rev Biomed Eng. 2023 Jun 8;25:311-331. doi: 10.1146/annurev-bioeng-092222-030857. Epub 2023 Apr 27.

本文引用的文献

1
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.遵守在 ClinicalTrials.gov 上报告临床试验结果的法律要求:一项队列研究。
Lancet. 2020 Feb 1;395(10221):361-369. doi: 10.1016/S0140-6736(19)33220-9. Epub 2020 Jan 17.
2
Prescription and Other Medication Use in Pregnancy.孕期用药情况。
Obstet Gynecol. 2018 May;131(5):789-798. doi: 10.1097/AOG.0000000000002579.
3
Update on Trial Registration 11 Years after the ICMJE Policy Was Established.ICMJE政策制定11年后的试验注册最新情况。
N Engl J Med. 2017 Jan 26;376(4):383-391. doi: 10.1056/NEJMsr1601330.
4
Clinical Trials Registration and Results Information Submission. Final rule.临床试验注册与结果信息提交。最终规则。
Fed Regist. 2016 Sep 21;81(183):64981-5157.
5
Why do pregnant women participate in research? A patient participation investigation using Q-Methodology.孕妇为何参与研究?一项运用Q方法学的患者参与情况调查。
Health Expect. 2017 Apr;20(2):188-197. doi: 10.1111/hex.12446. Epub 2016 Feb 26.
6
Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis.妊娠和产后期间的 HIV 事件与母婴 HIV 传播风险:系统评价和荟萃分析。
PLoS Med. 2014 Feb 25;11(2):e1001608. doi: 10.1371/journal.pmed.1001608. eCollection 2014 Feb.
7
Exclusion of pregnant women from industry-sponsored clinical trials.将孕妇排除在工业界赞助的临床试验之外。
Obstet Gynecol. 2013 Nov;122(5):1077-1081. doi: 10.1097/AOG.0b013e3182a9ca67.
8
Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review.系统评价研究发表偏倚和结果报告偏倚的实证证据——更新综述。
PLoS One. 2013 Jul 5;8(7):e66844. doi: 10.1371/journal.pone.0066844. Print 2013.
9
Enrolling pregnant women: issues in clinical research.招募孕妇:临床研究中的问题。
Womens Health Issues. 2013 Jan;23(1):e39-45. doi: 10.1016/j.whi.2012.10.003.
10
Women's views about participating in research while pregnant.女性对于孕期参与研究的看法。
IRB. 2012 Jul-Aug;34(4):1-8.